Shantharam Harish — SEC Form 4 filings
SEC reporting owner CIK 1976391. 7 Form 4 filings on record with FilingPulse; latest filed 2026-01-28.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-01-26 to 2026-01-28. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 75,000 shares, $58,402 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 9.
- Largest priced transaction: purchase of 75,000 shares @ $0.78 ($58,402) in ALX ONCOLOGY HOLDINGS INC, filed 2025-08-20.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC (ALXO) | Chief Financial Officer | 5 | 1 leg · 75,000 sh · $58,402 | — | 4 |
| CymaBay Therapeutics, Inc. (CBAY) | Chief Financial Officer | 2 | — | — | 5 |
Form 4 filings — Shantharam Harish
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-01-28 | 4 | ALX ONCOLOGY HOLDINGS INC (ALXO) | Grant/award (A): 303,000 (derivative) @ $0 | EDGAR |
| 2025-10-16 | 4 | ALX ONCOLOGY HOLDINGS INC (ALXO) | Grant/award (A): 198,750 (derivative) @ $0 | EDGAR |
| 2025-08-20 | 4 | ALX ONCOLOGY HOLDINGS INC (ALXO) | Purchase (P): 75,000 @ $0.78 | EDGAR |
| 2025-04-15 | 4 | ALX ONCOLOGY HOLDINGS INC (ALXO) | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2025-01-23 | 4 | ALX ONCOLOGY HOLDINGS INC (ALXO) | Grant/award (A): 600,000 (derivative) @ $0 | EDGAR |
| 2024-03-22 | 4 | CymaBay Therapeutics, Inc. (CBAY) | Disposition to issuer (D): 20,125 · Disposition to issuer (D): 360,000 (derivative) · Disposition to issuer (D): 74,750 (derivative) | EDGAR |
| 2024-01-26 | 4 | CymaBay Therapeutics, Inc. (CBAY) | Grant/award (A): 20,125 @ $0 · Grant/award (A): 74,750 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1976391 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →